Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy

Osman Kursat Arikan, Funda Uysal Tan, Tuba Kendi, Can Koc

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

We investigated the effectiveness of botulinum toxin A intramuscular injection for the management of masseteric muscle hypertrophy. Five patients with masseteric muscle hypertrophy were treated with botulinum toxin A (Dysport, Beaufour Ipsen, France). Clinical photographs were obtained before and between 3 and 6 months after application. Four patients are pleased with their present facial appearance. However, one patient reported mild discomfort about his appearance. Neither local nor general adverse effects were noted. Botulinum toxin A is a safe, easy-to-use, and effective nonsurgical option in the management of masseteric muscle hypertrophy. Its use is associated with a high degree of patient and physician satisfaction.

Original languageEnglish (US)
Pages (from-to)40-43
Number of pages4
JournalJournal of Otolaryngology
Volume35
Issue number1
DOIs
StatePublished - Feb 1 2006

Keywords

  • Botulinum toxin A
  • Masseteric muscle hypertrophy
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy'. Together they form a unique fingerprint.

  • Cite this